Results 251 to 260 of about 7,983,647 (299)

Treatment Adequacy and Baseline Risk Modify the Association Between Adjuvant Chemotherapy and Survival After Pathological Complete Response in Rectal Cancer. [PDF]

Int J Cancer
Wang C, Zhang X, An Y, Liu C, Wu B, Xiao Y, Lu J, Lin G.   +7 more
europepmc   +1 more source

A Case of Pathological Complete Response after "Conversion Surgery" for Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma. [PDF]

Surg Case Rep
Shirakawa Y, Yoh T, Ito T, Ogiso S, Ishii T, Fujimoto M, Haga H, Hatano E.   +7 more
europepmc   +1 more source

The utilization of CEUS and SWE for predicting pathological complete response to neoadjuvant chemotherapy for invasive breast cancer. [PDF]

Sci Rep
Wang Y, Jiang X, Jiao Y, Yang B, Wang P, Shen H, Xu J, Qi M, Shen H, Han J, Li D, Song D, Li J.   +12 more
europepmc   +1 more source

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [PDF]

Lancet, The, 2014
Background Pathological complete response has been proposed as a surrogate endpoint for prediction of long-term clinical benefit, such as disease-free survival, event-free survival (EFS), and overall survival (OS).
Sibylle Loibl, Nina Ditsch, Martine Piccart   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pathological complete response in breast cancer

The Lancet, 2015
www.thelancet.com Vol 385 January 10, 2015 113 Pathological complete response could better predict survival for women with hormone-receptor-negative breast cancer and with HER2-positive breast cancer treated with HER2 antagonists, but does not predict long-term outcome for hormone-positive or histologically low-grade tumours.
Alberto, Ocana, Bostjan, Seruga, Eitan, Amir   +2 more
  +7 more sources

Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response

Cancer, 2005
AbstractBACKGROUNDThe purpose of the current study was to test the hypothesis that a lower clinical TNM stage is associated with a higher rate of pathologic complete response (pathCR) in patients with esophageal carcinoma receiving preoperative chemoradiotherapy and to determine whether outcome after pathCR is related to clinical stage or treatment ...
Pooja, Rohatgi, Stephen G, Swisher, Arlene M, Correa, Tsung-T, Wu, Zhongxing, Liao, Ritsuko, Komaki, Garrett L, Walsh, Ara A, Vaporciyan, David C, Rice, Jack A, Roth, Jaffer A, Ajani   +10 more
openaire   +2 more sources

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Breast Cancer Research and Treatment, 2019
Many breast cancer patients receive sentinel lymph node biopsy after neoadjuvant chemotherapy (NAC). We evaluated the axillary pathologic complete response (pCR) in relation to achievement of breast pCR.We evaluated 1044 patients who were diagnosed with invasive breast cancer and were treated with NAC followed by curative surgery at the Samsung Medical
Hee Jun, Choi, Jai Min, Ryu, Isaac, Kim, Seok Jin, Nam, Seok Won, Kim, Jonghan, Yu, Jeong Eon, Lee, Se Kyung, Lee   +7 more
openaire   +2 more sources

Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response

Cancer/Radiothérapie, 2020
Neoadjuvant chemoradiotherapy (nCRT) followed by surgery in patients with resectable esophageal or esophagogastric junctional (GEJ) (Siewert I) cancer is associated with long term overall survival benefits. Up to one third of all patients submitted to nCRT present pathological complete response (pCR). 18F-fluorodeoxyglucose positron emission tomography
Cabral, Francisco, Cruz, A., Casaca, R., Monteiro, C., Ramos, P., Pedro, C., Brandão, F., Fonseca, R., Ratão, P., Saldado, L., Pinto, Iola, Abecasis, N.   +11 more
openaire   +3 more sources

Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

Annals of Surgical Oncology, 2015
There has been recent interest in using pathological complete response (pCR) as a potential surrogate endpoint for long-term outcomes in the neoadjuvant treatment of high-risk, early-stage breast cancer.We review the clinical trials that have contributed to our understanding of the association between pCR and long-term outcomes, describe the various ...
Patricia, Cortazar, Charles E, Geyer
openaire   +2 more sources

Complete pathological response after neoadjuvant treatment in locally advanced esophageal cancer predicts long term survival: A retrospective cohort study [PDF]

International Journal of Surgery, 2014
Background and objectivesEsophageal cancer incidence is gradually increasing worldwide. Studies have looked at the pathological stage rather than clinical stage as predictor of survival.
Shahrukh Rizvi, Aamir Ali Syed, Shahid Khattak   +2 more
exaly   +2 more sources